+

WO2002054078A3 - Procede de determination in vitro du vieillissement de la peau - Google Patents

Procede de determination in vitro du vieillissement de la peau Download PDF

Info

Publication number
WO2002054078A3
WO2002054078A3 PCT/EP2001/014812 EP0114812W WO02054078A3 WO 2002054078 A3 WO2002054078 A3 WO 2002054078A3 EP 0114812 W EP0114812 W EP 0114812W WO 02054078 A3 WO02054078 A3 WO 02054078A3
Authority
WO
WIPO (PCT)
Prior art keywords
skin
ageing
stress
skin ageing
vitro
Prior art date
Application number
PCT/EP2001/014812
Other languages
German (de)
English (en)
Other versions
WO2002054078A2 (fr
Inventor
Dirk Petersohn
Guenter Schmitt
Thomas Foerster
Original Assignee
Henkel Kommandigesellschaft Au
Dirk Petersohn
Guenter Schmitt
Thomas Foerster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kommandigesellschaft Au, Dirk Petersohn, Guenter Schmitt, Thomas Foerster filed Critical Henkel Kommandigesellschaft Au
Priority to AU2002219190A priority Critical patent/AU2002219190A1/en
Publication of WO2002054078A2 publication Critical patent/WO2002054078A2/fr
Publication of WO2002054078A3 publication Critical patent/WO2002054078A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un procédé pour déterminer in vitro le stress et/ou le vieillissement de la peau chez l'homme, des kits de tests et des biopuces servant à la détermination du stress et/ou du vieillissement de la peau, et l'utilisation de protéines, de molécules mRNA ou bien de fragments de protéines ou de molécules mRNA comme marqueurs du stress et/ou du vieillissement de la peau. La présente invention porte également sur un procédé d'essai visant à prouver l'efficacité d'agents pharmaceutiques ou cosmétiques agissant contre le stress et/ou le vieillissement de la peau, sur un procédé de criblage pour identifier des agents pharmaceutiques ou cosmétiques agissant contre le stress et/ou le vieillissement de la peau, ainsi que sur un procédé pour produire une préparation pharmaceutique ou cosmétique agissant contre le stress et/ou le vieillissement de la peau.
PCT/EP2001/014812 2001-01-03 2001-12-14 Procede de determination in vitro du vieillissement de la peau WO2002054078A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002219190A AU2002219190A1 (en) 2001-01-03 2001-12-14 Method for determining skin ageing in vitro

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10100122A DE10100122A1 (de) 2001-01-03 2001-01-03 Verfahren zur Bestimmung der Hautalterung in vitro
DE10100122.3 2001-01-03

Publications (2)

Publication Number Publication Date
WO2002054078A2 WO2002054078A2 (fr) 2002-07-11
WO2002054078A3 true WO2002054078A3 (fr) 2003-02-27

Family

ID=7669724

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/014812 WO2002054078A2 (fr) 2001-01-03 2001-12-14 Procede de determination in vitro du vieillissement de la peau

Country Status (3)

Country Link
AU (1) AU2002219190A1 (fr)
DE (1) DE10100122A1 (fr)
WO (1) WO2002054078A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2847268B1 (fr) * 2002-11-19 2006-09-29 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes soumises a un stress et des cellules vivantes non soumises a ce meme stress
FR2847269B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
FR2924613B1 (fr) * 2007-12-10 2012-12-21 Oreal Utilisation cosmetique de proteines de type hsp27.
JP5653684B2 (ja) * 2010-08-21 2015-01-14 日本メナード化粧品株式会社 皮膚損傷の程度を検査する方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015700A1 (fr) * 1991-02-28 1992-09-17 Anticancer, Inc. Procede d'histoculture de peau a l'etat naturel
WO1998053103A1 (fr) * 1997-05-21 1998-11-26 Clontech Laboratories, Inc. Ensembles d'acide nucleique
WO1999039210A1 (fr) * 1998-01-29 1999-08-05 Miller, Samuel Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
DK0584068T4 (da) * 1991-05-16 2004-06-14 Senetek Plc Fremgangsmåde og præparat til forbedring af de uheldige virkninger af ældning
WO1995016659A1 (fr) * 1993-12-15 1995-06-22 Avon Products, Inc. Nouveaux composes conjugues de retinoides et procedes de traitement du vieillissement de la peau
DE19742025A1 (de) * 1997-09-24 1999-03-25 Beiersdorf Ag Verwendung von Flavonen und Flavonoiden zur Hautaufhellung oder zur Verhinderung der durch oxidative Proteinaggregation hervorgerufenen Altersflecken

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015700A1 (fr) * 1991-02-28 1992-09-17 Anticancer, Inc. Procede d'histoculture de peau a l'etat naturel
WO1998053103A1 (fr) * 1997-05-21 1998-11-26 Clontech Laboratories, Inc. Ensembles d'acide nucleique
WO1999039210A1 (fr) * 1998-01-29 1999-08-05 Miller, Samuel Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BOXMAN I L A ET AL: "Proteomic analysis of skin irritation reveals the induction of HSP27 by sodium lauryl sulphate in human skin.", THE BRITISH JOURNAL OF DERMATOLOGY. ENGLAND MAY 2002, vol. 146, no. 5, May 2002 (2002-05-01), pages 777 - 785, XP002217295, ISSN: 0007-0963 *
COURCHESNE P L ET AL: "Identification of Proteins by Matrix-Assisted Laser Desorption/Ionization Mass Spectroscopy Using Peptide and Fragment Ion Masses (from 2-D Proteome Analysis Protocols, Ed. A. J. Link)", METHODS IN MOLECULAR BIOLOGY, HUMANA PRESS INC., CLIFTON, NJ, US, vol. 112, 1999, pages 487 - 511, XP002103063 *
FENGA C ET AL: "Heat Shock Protein 27 is overexpressed in the skin of bitumen exposed workers. Early observations.", BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE. ITALY 2000 NOV-DEC, vol. 76, no. 11-12, November 2000 (2000-11-01), pages 81 - 86, XP001117652, ISSN: 0037-8771 *
HAYDEN P J ET AL: "Changes in cancer-related gene expression in an in vitro human skin model following UVB-irradiation.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 114, no. 4, April 2000 (2000-04-01), 61st Annual Meeting of the Society for Investigative Dermatology.;Chicago, Illinois, USA; May 10-14, 2000, pages 824, XP002217294, ISSN: 0022-202X *
KATZ ANNE B ET AL: "A partial catalog of proteins secreted by epidermal keratinocytes in culture.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 112, no. 5, May 1999 (1999-05-01), pages 818 - 821, XP002217163, ISSN: 0022-202X *
TRAUTINGER FRANZ ET AL: "Stress proteins in the cellular response to ultraviolet radiation.", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B BIOLOGY, vol. 35, no. 3, 1996, pages 141 - 148, XP002217161, ISSN: 1011-1344 *
WEIDNER CHRISTIAN ET AL: "Acute effects of substance P and calcitonin gene-related peptide in human skin: A microdialysis study.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 115, no. 6, December 2000 (2000-12-01), pages 1015 - 1020, XP002217162, ISSN: 0022-202X *

Also Published As

Publication number Publication date
DE10100122A1 (de) 2002-07-11
AU2002219190A1 (en) 2002-07-16
WO2002054078A2 (fr) 2002-07-11

Similar Documents

Publication Publication Date Title
WO2002053773A3 (fr) Procede pour la determination in vitro des agressions ou du vieillissement cutanes
WO2002053774A3 (fr) Procede pour la determination de l'homeostasie cutanee
WO2003016475A3 (fr) Sequences d'acides nucleiques et d'acides amines intervenant dans la douleur
EP2450360A3 (fr) (S)-N-Méthylnaltrexone
ZA200500091B (en) System and method for the preparation of arrays of biological or other molecules
WO2004032713A3 (fr) Scellants pour la peau et autres tissus
BRPI0513029A (pt) método para produzir uma proteìna de eritropoietina carbamilada, proteìna de eritropoietina carbamilada, composto, composição farmacêutica, métodos de tratamento de uma doença ou condição crÈnica, sub-crÈnica e aguda e de tratamento de uma doença do sistema nervoso central ou sistema nervoso periférico, e, uso de um composto
WO2004043906A3 (fr) Utilisation de trans-pellitorine comme substance aromatique
WO2003076592A3 (fr) Nouvelle methode d'administration et de synthese intracellulaire de molecules sirna
WO2004007743A3 (fr) Utilisation d'acides nucleiques cpg dans les maladies a prions
WO2007021886A3 (fr) Compositions de memapsine 2 tronquee et traitements associes
AU2002315200A1 (en) Production metering and well testing system background of the invention
ATE296607T1 (de) Zubereitung zur entfernung von abnormen keratinmaterial
WO2004081229A3 (fr) Compositions a activite hematopoietique et immunitaire
WO2007134350A8 (fr) Utilisation d'un anticorps
WO2002054078A3 (fr) Procede de determination in vitro du vieillissement de la peau
WO2004059002A3 (fr) Procede de determination de l'homeostasie de peau pileuse
AU2003277046A1 (en) Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof
WO2004059001A3 (fr) Procede de determination de marqueurs de la peau du visage humain
WO2002031496A3 (fr) Procede de determination in vitro du vieillissement de la peau
WO2004005540A3 (fr) Utilisations de substances qui se lient a ngal pour le diagnostic et le traitement de maladies cancereuses
WO2005028671A3 (fr) Procede pour determiner des marqueurs de cycle capillaire
WO2004089982A3 (fr) Variantes april et leurs procedes
WO2004016212A3 (fr) Methodes et compositions de ciblage de lysosomes secretoires
ITMI20011687A0 (it) Processo per la preparazione in emulsione di particelle polimeriche composite

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BG BR BY CA CN CZ DZ HU ID IL IN JP KR MX NO NZ PL RO RU SG SI SK UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BG BR BY CA CN CZ DZ HU ID IL IN JP KR MX NO NZ PL RO RU SG SI SK UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载